#

Product Categories

Daicel’s comprehensive range of Impurity Standards ensures the highest quality in pharmaceutical development and manufacturing. Our meticulously characterized reference standards help pharmaceutical companies meet stringent regulatory requirements from FDA, EMA, and ICH guidelines.

With over two decades of expertise in pharmaceutical standardization, we provide ISO 14000 accredited impurity reference materials that enable accurate quantification, identification, and quality control of active harmaceutical
ingredients (APIs) and finished products.

Whether you’re developing new formulations, conducting stability testing, or ensuring batch-to-batch consistency, our impurity standards are designed to support your compliance and quality objectives throughout the drug lifecycle.

Choose your Category

Importance of impurity standards

  • Quality Assurance & Control
    Enable accurate quantification and identification of related substances
    through validated analytical methods (HPLC, GC, LC-MS), maintaining
    batch-to-batch consistency and product safety.
  • Accelerated Development Timeline
    Reduce development cycles by providing pre-characterized reference standards,
    eliminating the need for in-house standard development and characterization,
    allowing faster time-to-market.
  • Cost Efficiency
    Minimize analytical testing costs through reliable reference materials that
    reduce method re-development, increase analytical success rates, and prevent
    expensive product failures during stability studies.
  • Risk Mitigation & Patient Safety
    Detect potential genotoxic impurities, process contaminants, and degradation
    products early in development, ensuring patient safety and preventing recalls,
    litigation, and brand reputation damage.
  • Competitive Advantage
    Access cutting-edge impurity standards for novel drug classes and emerging
    therapeutic areas, enabling faster innovation and market entry ahead of
    competitors.

    Contact Us for More Information


    FAQ

    Yes, Daicel offers comprehensive pharmaceutical services including custom synthesis and supply of impurity standards to support regulatory filings across all therapeutic areas. We specialize in providing API impurity standards for oncology manufacturers with full GMP compliance and FDA expertise.

    Daicel synthesizes and certifies high-quality impurity standards , auditable facilities, maintaining rigorous Quality Management Systems with ISO 9001:2015 and ISO 45001 :2018 certifications for unwavering reliability.

    Daicel offers custom synthesis of target impurities with known structures, plus characterization and isolation of unknown impurities through preparative HPLC/SFC chromatography, peptide synthesis, and labelled compound development.

    Pharmaceutical impurity standards serve as reference materials for detecting and quantifying impurities using analytical techniques like HPLC, GC, and LC-MS, supporting method validation and ensuring product quality. Essential for regulatory submissions.

    Back to Top
    Product has been added to your cart